(Body fat contains enzymes that can convert testosterone into estrogen
This will reduce nausea and vomiting
Both options are clinically proven to support meaningful weight reduction, but studies suggest: Tirzepatide may lead to more rapid and significant weight loss due to its dual receptor action
First approved in 2021, Wegovy is the only FDA-approved semaglutide treatment for weight loss and the medicine that changed how healthcare professionals (HCPs) treat people with obesity as the first weekly GLP-1 option for chronic weight management
27 In the initial stages, local inflammation and ulceration of the intestinal mucosa occur, and the most common symptoms include abdominal pain, diarrhea, blood in the stool, anemia, and fatigue
So the question that matters is not whether GLP-1 is good or bad for retail